|
HS Code |
128262 |
| Product Name | 8-Azahypoxanthine |
| Cas Number | 123-42-2 |
| Molecular Formula | C5H4N6O |
| Molecular Weight | 164.13 g/mol |
| Appearance | White to off-white powder |
| Melting Point | 343-345 °C (dec.) |
| Solubility In Water | Slightly soluble |
| Synonyms | 8-Aza-7H-purine-6-one |
| Chemical Class | Purine analog |
| Pubchem Cid | 76908 |
As an accredited 8-Azahypoxanthine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 8-Azahypoxanthine is supplied in a 5g amber glass vial with secure screw cap, labeled with product details and safety information. |
| Shipping | 8-Azahypoxanthine is shipped in compliance with all relevant chemical safety regulations. It is securely packaged in sealed containers to prevent contamination or moisture exposure. The shipment is labeled appropriately with hazard information and handled by trained personnel. Delivery is prompt, ensuring the compound’s integrity and stability upon arrival. |
| Storage | 8-Azahypoxanthine should be stored in a tightly sealed container, protected from moisture and direct sunlight. Keep at room temperature (15–25°C), away from incompatible substances such as strong acids or oxidizers. Store in a well-ventilated, cool, dry area and handle using appropriate safety precautions, including gloves and eyewear, to prevent inhalation, ingestion, or skin contact. |
Applications of 8-Azahypoxanthine in Industrial ManufacturingAs a specialized manufacturer of 8-Azahypoxanthine, we supply this purine analog to downstream sectors where high-purity nucleic acid components are required for advanced biotechnological and pharmaceutical synthesis. Here, we outline key industrial application fields and the integration of 8-Azahypoxanthine into recognized process chains. 1. API Intermediate for Antiviral PharmaceuticalsPharmaceutical producers incorporate 8-Azahypoxanthine as a core building block in the synthesis routes of antiviral APIs. It serves as a purine scaffold in nucleoside analogs targeting viral replication, especially in the development of lead compounds for therapy pipelines against hepatitis C and retroviral infections. Process chemists adjust molar input and purification methods to comply with regulatory purity and residual solvent specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Research-Grade Nucleic Acid Probe ManufacturingManufacturers of RNA/DNA probe kits source 8-Azahypoxanthine as a labeled base analog in modified oligonucleotide libraries. It provides selective hydrogen bonding for mutagenicity or base recognition studies in genomics research tools. Formulators calibrate the proportion of base analogs to maintain probe hybridization efficiency and minimize background interference. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Cell Culture Medium Additive for BioproductionProducers of animal cell culture media and bioprocess supplements use 8-Azahypoxanthine as a purine source and selective agent for hybridoma and recombinant cell line screening. It replaces hypoxanthine or acts in HAT media for monoclonal antibody research and upstream cell engineering. QC teams adjust supplementation rates based on serum content, cell line tolerance, and downstream scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic Reagent Ingredient in Biochemical AssaysManufacturers of diagnostic enzymatic assay kits employ 8-Azahypoxanthine for enzyme substrate or inhibitor assays, particularly in xanthine oxidase and purine salvage pathway studies. Analysts set concentrations to match enzyme kinetics and ensure lot-to-lot reproducibility in high-throughput clinical diagnostics. Strict microanalysis controls verify absence of interfering impurities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Precursor in Fine Chemical Synthesis for Purine DerivativesProducers in the fine chemicals sector utilize 8-Azahypoxanthine as a synthetic precursor for custom purine and triazole compounds. Process chemists exploit the N8 position for functionalization toward specialized ligands and catalysts. Reaction sequences depend on protecting group strategy and regioselectivity requirements, and QC groups monitor for residual starting material throughout post-reaction purification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 8-Azahypoxanthine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 8-Azahypoxanthine takes more than just technical know-how; it requires attention to detail in every batch. Years of handling this compound have taught us that the synthesis process consistently tests our process control skills. This molecule, known by its chemical name 1,2,3,6-Tetrahydro-8H-purine-6-thione, has become a staple for researchers working on nucleic acid metabolism, enzyme research, and analog development. In our facility, the product comes as a clean, white to off-white crystalline powder, with a purity level routinely above 99% by HPLC. We measure identity sharply, turning to NMR and mass spectrometry for confirmation. Handling 8-Azahypoxanthine day in and day out, we notice even small impurities, so we put in real effort to keep them out.
Often, a customer’s first question is about the consistency between lots. We track every synthesis step, because someone’s work might depend on results from our material matching what they saw last year. The stakes are obvious when you supply research-grade chemicals. The use cases for 8-Azahypoxanthine run broad across the life sciences—mainly as a building block and inhibitor analogue in labs studying purine metabolism, nucleoside transformations, and genetic replication models. We get calls from teams in pharmaceutical R&D, academic biochemistry departments, and companies screening for enzyme inhibitors. These groups rely on small differences in molecular structure to make a big downstream impact.
In our experience, 8-Azahypoxanthine really benefits from careful packaging. Moisture control matters. This compound does not flow or behave like simple salts—it cakes under high humidity, which can interfere with accurate weighing or dispensing into labware. In our packing room, we work under dry conditions and use robust sealing. We check not just the chemical's purity but its physical attributes each time—particle size, flow properties, and the way it dissolves in water or buffer solution. Some competitors ship it in basic plastic, but we prefer high-barrier foil or amber glass bottles. The loss in weight from exposure is minor but cumulative, and it’s a detail we care to manage.
For those actually working with it, we offer as much transparency as possible about solubility. In water at room temperature, you get reasonable solubility, but once you cross 37°C, you’ll see markable improvements. Solution clarity matters for assays, so we invest time into making sure particulate free solutions come out of our product. More often than not, users ask about DMSO compatibility or whether the molecule holds up in typical aqueous buffers. We’ve done the checks in-house and share protocols, saving time for repeat users.
Many research groups compare 8-Azahypoxanthine with the more familiar hypoxanthine or allopurinol. The structural differences are subtle but meaningful. 8-Azahypoxanthine swaps one of the nitrogen positions in the purine ring, which changes both the electronic structure and the hydrogen-bonding pattern. This seemingly small shift leads to measurable changes in binding to certain enzymes—especially those involved in purine metabolism pathways. From a practical angle, we see researchers using 8-Azahypoxanthine when regular inhibitors or substrates don’t deliver selective results. It brings a distinct inhibition profile and sometimes gives a window into alternate binding interactions.
Production isn’t as straightforward as with standard purines. Extrusion and purification steps for 8-Azahypoxanthine add additional time and chemical demands. The yield can drop suddenly based on how old the starting material is, or if batch temperature control wavers by more than a degree. Purification requires patience—chromatography for this analog gets tricky because its polarity is different from close cousins. These hands-on lessons inform our customer support. We encourage buyers to request specific info or even additional single-lot samples for method development. This isn’t just warehouse inventory; every gram we send out has been tracked, checked, and verified by someone who knows what to look for.
The practical importance of 8-Azahypoxanthine traces back to how enzymes distinguish between purine analogs. Researchers often substitute this molecule for natural bases or their analogues in model systems to probe the selectivity and mechanism of various hydrolases, kinases, or transferases. A classic use appears in studies on xanthine oxidase and related enzymes, where it serves as both substrate and inhibitor analog. These details come up frequently in literature, but in our conversations with principal investigators, we learn what actually happens in the lab. High-purity, well-characterized 8-Azahypoxanthine lets scientists spot subtle kinetic shifts or binding changes that low-grade material might mask.
The difference between solid chemical specs on a sheet and the outcome in a real assay can be large. We’ve seen researchers spend weeks troubleshooting interference before discovering low-level contaminants in purchased material. By tending to our crystallization and drying protocols, and running each batch through full analysis, we cut down on those headaches. Our own QC managers stress that speed is no substitute for attention; passing a batch that matches specs on one test won’t do if it fails another. This discipline shows in our return-customer base. Repeat labs appreciate having reproducible results—study to study, year to year.
Producing 8-Azahypoxanthine at kilogram scale highlights a different set of hurdles. Small batch synthesis often masks issues that balloon in larger reactors—heat management, stirring efficiency, and reaction time all change. Our initial runs delivered solid yields, but scaling by even a factor of ten meant rethinking how to add reactants and extract intermediates. The product’s tendency to form stubborn slurries at intermediate steps forced us to redesign some filtration and drying equipment. We learned that small crystal forms clog filters more easily than larger ones, which led to extended downtimes and hard lessons in material handling.
We attack these issues with direct investment—not just in equipment, but in technician training. Our best process improvements came from hands-on trial and error, not just theory or borrowed protocols. You don’t realize the subtle contribution of a new agitator fin shape or a jacketed vessel until you’ve spent months scraping out stubborn residue by hand. Each improvement trickles down to the product quality and consistency we can offer. The result is a material that not only meets published specs but behaves reliably during handling and use, regardless of whether it’s ordered at gram or multi-kilo scale.
Our longest relationships with R&D customers hinge on honest back-and-forth. After a major order for 8-Azahypoxanthine leaves our floor, we usually check in with the client within weeks—asking for real-world impressions. Not every batch lands perfectly; sometimes even minor changes in batch drying conditions show up as differences in assay readings. We keep the line open for complaints and observations, using the data to tweak our process.
Some groups have specific needs. A recurring request comes from teams wanting extra documentation with their shipments—chromatograms, trace moisture content, or a full impurity profile. Others focus on the physical form, asking for powder instead of crystalline, or desiring extra attention to particle size. We fill these orders by keeping a flexible production and QC pipeline. Having a pure, reliable 8-Azahypoxanthine on the shelf means little if the batch doesn’t fit the end use. Our reputation gets built, job by job, on listening to those in the lab and acting on what we hear.
To stay grounded in real expertise, we continually benchmark our own products against leading reference standards. We regularly analyze side-by-side with NIST and USP materials, where available, and keep a running file of comparison data. Deviations trigger a review, sometimes sending us back to synthesis or purification tables to look for system drifts or overlooked byproducts. This hands-on, empirical approach sets the tone for what we send to market. We’re not in the business of moving anonymous powder across markets. We produce to serve those who need confidence in the chemistry itself—educators, drug discovery teams, and molecular biologists who turn these materials into results that move their work forward.
Documentation transparency supports our standing. Each lot ships with analytical data that goes beyond the minimum. Our in-house chemists write the reports because they’re the ones actually running the tests. The chain of custody and authenticity gets logged at every step—those who buy from us know exactly what went into their bottle, from raw reagents to finished material.
Producing 8-Azahypoxanthine or any purine analog today involves more responsibility than years ago. Stringent environmental, safety, and workplace health standards pressed us to revisit every synthesis step. We invested in closed-system handling for volatile intermediates, solvent-recovery operations, and upgraded fire suppression systems in storage areas. The days of accepting solvent losses as overhead are over. We developed protocols to recycle and curb our waste streams, reducing both cost and environmental footprint.
Worker safety matters. Many steps in 8-Azahypoxanthine synthesis generate gases or exotherms. Our operators are trained not just on standard personal protection, but on the chemistry itself—understanding what a color change or odd aroma might signal in a reaction. We use the lessons learned from audits and near-miss events to rewrite internal guidelines, going beyond standard compliance. The priority each day is to send every team member home as healthy as they started their shift.
There is a direct connection between years spent on the production floor and the quality of the 8-Azahypoxanthine we supply. Beyond technical skill and instrument calibration, experience matters—recognizing the signs of a clean crystallization, smelling a hint of an off-odor that points to an impurity, or spotting a small shift in how the material pours or packs. None of these insights surface on a spec sheet, but they matter to the people who use our product. By anchoring our work in real manufacturing knowledge, we deliver more than just chemical compounds. We serve as a dependable partner to every researcher trusting our material to drive their project forward.
With each improvement in our process, our aim stays the same: to deliver authentic, high-quality 8-Azahypoxanthine that works as promised—batch after batch, shipment after shipment. Reliability in supply and results stems from manufacturing experience, attention to real-world use, and respect for the science our customers do every day.